GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 105 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $10,000 | +66.7% | 400 | 0.0% | 0.00% | – |
| Q4 2020 | $6,000 | 0.0% | 400 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $6,000 | 0.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $6,000 | +200.0% | 400 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | -33.3% | 400 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | +50.0% | 400 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -33.3% | 400 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | -99.9% | 400 | 0.0% | 0.00% | – |
| Q1 2018 | $2,176,000 | +30.5% | 400 | 0.0% | 0.00% | – |
| Q4 2017 | $1,668,000 | -56.7% | 400 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $3,852,000 | -18.6% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $4,732,000 | -7.7% | 400 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $5,128,000 | +4.7% | 400 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $4,896,000 | +3.7% | 400 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $4,720,000 | +35.6% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $3,480,000 | +37.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $2,540,000 | +84566.7% | 400 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $3,000 | -25.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $4,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|